The proteoglycan repertoire of lymphoid cells

Glycoconjugate Journal

Volumn 29, Issue 7, 2012, Pages 513-523

  Fadnes, Bodil ^a   Husebekk, Anne ^a,b   Svineng, Gunbjørg ^a   Rekdal, Oystein ^a,c   Yanagishita, Masaki ^d   Kolset, Svein O ^e   Uhlin Hansen, Lars ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c LYTIX BIOPHARMA AS   (Norway)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Glypican; Lymphoid cells; Proteoglycan; Serglycin; Syndecan

Indexed keywords

GLYCOPROTEIN; GLYPICAN; HEPARAN SULFATE; MESSENGER RNA; PROTEOGLYCAN; SERGLYCIN; SYNDECAN 4; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SELECTION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOID CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HEPARITIN SULFATE; HUMANS; LYMPHOCYTES; NEOPLASM PROTEINS; PROTEOGLYCANS; RNA, MESSENGER; RNA, NEOPLASM; SYNDECAN-4; VESICULAR TRANSPORT PROTEINS;

EID: 84865725994     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-012-9427-9     Document Type: Article

References (41)

1. Kjellen, L., Lindahl, U.: Proteoglycans: Structures and interactions. Annu. Rev. Biochem. 60, 443-475 (1991)
2. Kirn-Safran, C., Farach-Carson, M.C., Carson, D.D.: Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cell Mol Life Sci. 66, 3421-3434 (2009)
3. Kolset, S.O., Tveit, H.: Serglycin-structure and biology. Cell Mol Life Sci. 65, 1073-1085 (2008)
4. Esko, J.D., Selleck, S.B.: Order out of chaos: Assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435-471 (2002) (Pubitemid 34800227)
5. Casu, B., Choay, J., Ferro, D.R., Gatti, G., Jacquinet, J.C., Petitou, M., Provasoli, A., Ragazzi, M., Sinay, P., Torri, G.: Controversial glycosaminoglycan conformations. Nature 322, 215-216 (1986)
6. Kolset, S.O., Pejler, G.: Serglycin: A structural and functional chameleon with wide impact on immune cells. J. Immunol. 187, 4927-4933 (2011)
7. Duelli, A., Ronnberg, E., Waern, I., Ringvall, M., Kolset, S.O., Pejler, G.: Mast cell differentiation and activation is closely linked to expression of genes coding for the serglycin proteoglycan core protein and a distinct set of chondroitin sulfate and heparin sulfotransferases. J. Immunol. 183, 7073-7083 (2009)
8. Fransson, L.A.: Glypicans. Int. J. Biochem. Cell Biol. 35, 125-129 (2003)
9. Esko, J.D., Lindahl, U.: Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169-173 (2001) (Pubitemid 32656238)
10. Filmus, J.: Glypicans in growth control and cancer. Glycobiology 11, 19R-23R (2001) (Pubitemid 32471991)
11. Bishop, J.R., Schuksz, M., Esko, J.D.: Heparan sulphate proteoglycans fine-Tune mammalian physiology. Nature 446, 1030-1037 (2007) (Pubitemid 46676065)
12. Theocharis, A.D., Skandalis, S.S., Tzanakakis, G.N., Karamanos, N.K.: Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J. 277, 3904-3923 (2010)
13. O'Connell, F.P., Pinkus, J.L., Pinkus, G.S.: CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am. J. Clin. Pathol. 121, 254-263 (2004) (Pubitemid 38140131)
14. Chung, J.S., Dougherty, I., Cruz Jr., P.D., Ariizumi, K.: Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation. J. Immunol. 179, 5778-5784 (2007)
15. Teixe, T., Nieto-Blanco, P., Vilella, R., Engel, P., Reina, M., Espel, E.: Syndecan-2 and -4 expressed on activated primary human CD4 + lymphocytes can regulate T cell activation. Mol. Immunol. 45, 2905-2919 (2008)
16. Grujic, M., Christensen, J.P., Sorensen, M.R., Abrink, M., Pejler, G., Thomsen, A.R.: Delayed contraction of the CD8+ T cell response toward lymphocytic choriomeningitis virus infection in mice lacking serglycin. J. Immunol. 181, 1043-1051 (2008)
17. Chung, J.S., Shiue, L.H., Duvic, M., Pandya, A., Cruz Jr., P.D., Ariizumi, K.: Sezary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surface. Blood 117, 3382-3390 (2011)
18. Sebestyen, A., Berczi, L., Mihalik, R., Paku, S., Matolcsy, A., Kopper, L.: Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas. Br. J. Haematol. 104, 412-419 (1999) (Pubitemid 29083353)
19. Carbone, A., Gloghini, A., Gattei, V., Degan, M., Improta, S., Aldinucci, D., Canzonieri, V., Perin, T., Volpe, R., Gaidano, G., Zagonel, V., Pinto, A.: Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody BB4 and express human syndecan-1. Blood 89, 3787-3794 (1997) (Pubitemid 27227103)
20. Niemann, C.U., Kjeldsen, L., Ralfkiaer, E., Jensen, M.K., Borregaard, N.: Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia. Leukemia 21, 2406-2410 (2007) (Pubitemid 350148881)
21. Theocharis, A.D., Seidel, C., Borset, M., Dobra, K., Baykov, V., Labropoulou, V., Kanakis, I., Dalas, E., Karamanos, N.K., Sundan, A., Hjerpe, A.: Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro. J. Biol. Chem. 281, 35116-35128 (2006) (Pubitemid 46036551)
22. Carter, C.S., Leitman, S.F., Cullis, H., Muul, L.M., Nason-Burchenal, K., Rosenberg, S.A., Klein, H.G.: Use of a continuous-flow cell separator in density gradient isolation of lymphocytes. Transfusion 27, 362-365 (1987) (Pubitemid 17106185)
23. Uhlin-Hansen, L., Yanagishita, M.: Differential effect of brefeldin A on the biosynthesis of heparan sulfate and chondroitin/dermatan sulfate proteoglycans in rat ovarian granulosa cells in culture. J. Biol. Chem. 268, 17370-17376 (1993) (Pubitemid 23236976)
24. Shively, J.E., Conrad, H.E.: Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 15, 3932-3942 (1976)
25. Schmittgen, T.D., Livak, K.J.: Analyzing real-Time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108 (2008) (Pubitemid 351818697)
26. Modiano, J.F., Mayor, J., Ball, C., Chitko-McKown, C.G., Sakata, N., Domenico-Hahn, J., Lucas, J.J., Gelfand, E.W.: Quantitative and qualitative signals determine T-cell cycle entry and progression. Cell. Immunol. 197, 19-29 (1999)
27. Bowman, K.G., Bertozzi, C.R.: Carbohydrate sulfotransferases: Mediators of extracellular communication. Chem. Biol. 6, R9-R22 (1999) (Pubitemid 29363039)
28. Grujic, M., Braga, T., Lukinius, A., Eloranta, M.L., Knight, S.D., Pejler, G., Abrink, M.: Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage. J. Biol. Chem. 280, 33411-33418 (2005) (Pubitemid 41397139)
29. David, G., Bai, X.M., Van der Schueren, B., Cassiman, J.J., Van den Berghe, H.: Developmental changes in heparan sulfate expression: In situ detection with mAbs. J Cell Biol. 119, 961-975 (1992)
30. Metkar, S.S., Wang, B., Aguilar-Santelises, M., Raja, S.M., Uhlin-Hansen, L., Podack, E., Trapani, J.A., Froelich, C.J.: Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme Bserglycin complexes into target cells without plasma membrane pore formation. Immunity 16, 417-428 (2002) (Pubitemid 34260919)
31. Raja, S.M., Wang, B., Dantuluri, M., Desai, U.R., Demeler, B., Spiegel, K., Metkar, S.S., Froelich, C.J.: Cytotoxic cell granulemediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J. Biol. Chem. 277, 49523-49530 (2002) (Pubitemid 36014390)
32. Boivin, W.A., Cooper, D.M., Hiebert, P.R., Granville, D.J.: Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab Invest. 89, 1195-1220 (2009)
33. Fehniger, T.A., Cai, S.F., Cao, X., Bredemeyer, A.J., Presti, R.M., French, A.R., Ley, T.J.: Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26, 798-811 (2007) (Pubitemid 46907665)
34. Chowdhury, D., Lieberman, J.: Death by a thousand cuts: Granzyme pathways of programmed cell death. Annu. Rev. Immunol. 26, 389-420 (2008) (Pubitemid 351611623)
35. Chung, J.S., Bonkobara, M., Tomihari, M., Cruz Jr., P.D., Ariizumi, K.: The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses. Eur. J. Immunol. 39, 965-974 (2009)
36. MacDermott, R.P., Nash, G.S., Bertovich, M.J., Merkel, N.S., Weinrieb, I.J.: Human B-cell mitogenic responsiveness to lectins: The requirement for T cells. Cell. Immunol. 38, 198-202 (1978) (Pubitemid 8364111)
37. Ythier, A., Delmon, L., Reinherz, E., Nowill, A., Moingeon, P., Mishal, Z., Bohuon, C., Hercend, T.: Proliferative responses of circulating human NK cells: Delineation of a unique pathway involving both direct and helper signals. Eur. J. Immunol. 15, 1209-1215 (1985) (Pubitemid 16179053)
38. Ronnberg, E., Pejler, G.: Serglycin: The master of the mast cell. Methods Mol Biol. 836, 201-217 (2012)
39. Patel, M., Yanagishita, M., Roderiquez, G., Bou-Habib, D.C., Oravecz, T., Hascall, V.C., Norcross, M.A.: Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retroviruses. 9, 167-174 (1993) (Pubitemid 23121578)
40. Roderiquez, G., Oravecz, T., Yanagishita, M., Bou-Habib, D.C., Mostowski, H., Norcross, M.A.: Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol. 69, 2233-2239 (1995)
41. Oravecz, T., Pall, M., Wang, J., Roderiquez, G., Ditto, M., Norcross, M.A.: Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans. J. Immunol. 159, 4587-4592 (1997) (Pubitemid 127470621)